MarketBeat provided analyst recommendations and compared investment factors for Addex Therapeutics and XORTX Therapeutics.
2 reports, 2 independent
Updated Jun 27
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat provided analyst recommendations and compared investment factors for Addex Therapeutics and XORTX Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Addex Therapeutics
Swiss public company
-
MarketBeat
American personal finance blog
Related events
- MarketBeat aggregated analyst recommendations and price targets for BioMarin Pharmaceutical and Abeona Therapeutics Inc.
- MarketBeat summarized current ratings and price targets for Arcturus Therapeutics.
- MarketBeat is providing analyst ratings and targets for Addentax Group and Expeditors International of Washington, Inc.
- Addex Therapeutics and Bayer Aktiengesellschaft are being compared as healthcare companies.
- Addex Therapeutics and Enanta Pharmaceuticals are being analyzed as competing small-cap healthcare companies.